BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/30/2018 6:53:54 AM | Browse: 1113 | Download: 1573
 |
Received |
|
2018-06-27 00:03 |
|
Peer-Review Started |
|
2018-06-30 03:49 |
|
To Make the First Decision |
|
2018-07-09 08:08 |
|
Return for Revision |
|
2018-07-11 02:12 |
|
Revised |
|
2018-08-06 15:38 |
|
Second Decision |
|
2018-08-10 08:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-08-13 03:09 |
|
Articles in Press |
|
2018-08-13 03:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-08-18 21:38 |
|
Typeset the Manuscript |
|
2018-08-28 10:04 |
|
Publish the Manuscript Online |
|
2018-08-30 06:53 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Editorial |
| Article Title |
Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alberto Tommasini, Andrea Magnolato and Irene Bruno |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| IRCCS Burlo Garofolo |
RC24/17 |
|
| Corresponding Author |
Alberto Tommasini, MD, PhD, Adjunct Professor, Medical Assistant, Senior Scientist, Department of Pediatrics, Institute of Maternal and Child Health, IRCCS Burlo Garofolo, via dell’Istria 65/1, Trieste 34137, Italy. alberto.tommasini@burlo.trieste.it |
| Key Words |
X-severe combined immunodeficiency; Primary immunodeficiency; Beta thalassemia; Spinal muscular atrophy; Bioethics; History of medicine; Precision medicine; Genetics |
| Core Tip |
Precision therapies are heralded to change the prognosis of rare and severe genetic disorders. However, the new treatments are not always curative and what can be viewed on one hand as a partial improvement, on the other may result, at least for some patients, in prolonged suffering. During this period of change, great hopes but unpredictable outcomes can mark the lives of patients. Recalling and considering the ethical debates on historical cases can help doctors in giving the right advice to the families of patients with rare and severe disorders. |
| Publish Date |
2018-08-30 06:53 |
| Citation |
Tommasini A, Magnolato A, Bruno I. Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering. World J Clin Pediatr 2018; 7(3): 75-82 |
| URL |
http://www.wjgnet.com/2219-2808/full/v7/i3/75.htm |
| DOI |
http://dx.doi.org/10.5409/wjcp.v7.i3.75 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
